Human papillomavirus vaccines

J Schiller, D Lowy, L Markowithz - Vaccines. 6th ed. Philadelphia …, 2012 - books.google.com
Human papilloma virus (HPV) infections, which are common, produce epithelial lesions of
the nongenital and genital skin and mucous membranes. Although most infections are …

Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented?

AR Shaw - Gynecologic oncology, 2005 - Elsevier
INTRODUCTION.: There are some 30–40 genotypes of human papillomavirus (HPV) that
cause anogenital lesions in humans, primarily cervical, vaginal, and vulvar dysplasias and …

Indications and efficacy of the human papillomavirus vaccine

AA Hakim, PS Lin, S Wilczynski, K Nguyen… - … treatment options in …, 2007 - Springer
Opinion statement In the United States, there are 11,150 cases and 3670 deaths projected
due to invasive cervical cancer for 2007. Approximately 500,000 new cases and 274,000 …

Introducing human papillomavirus vaccines—questions remain

J Paavonen, M Lehtinen - Annals of Medicine, 2008 - Taylor & Francis
Genital human papillomavirus (HPV) infection and HPV‐associated cervical and other
anogenital cancers are significant public health problems. HPV 16 and HPV 18 are …

Human papillomavirus vaccination

JT Cox, JM Palefsky - UpToDate. Waltham, MA. Accessed September, 2018 - uptodate.com
INTRODUCTION—Human papillomavirus (HPV) is a sexually transmitted pathogen that
causes anogenital and oropharyngeal disease in males and females. Persistent viral …

Worldwide impact of the human papillomavirus vaccine

AA Hakim, TA Dinh - Current treatment options in oncology, 2009 - Springer
Opinion statement Nearly 500,000 new cases of cervical cancer and 274,000 cervical
cancer deaths are occurring worldwide each year. Approximately 80% of the 500,000 new …

Human papillomavirus vaccination: past, present and future

G Aimagambetova, A Azizan - Vaccines, 2022 - mdpi.com
The link between human papillomavirus (HPV) infection and different diseases has been
well-established since more than four decades ago [1, 2]. Moreover, high-risk HPV types …

[PDF][PDF] Report of the consultation on human papillomavirus vaccines: World Health Organization, Geneva, April 2005

World Health Organization - 2005 - apps.who.int
Vaccines against HPV infections have the potential to be a more practical and cost–effective
way to reduce the incidence of cervical cancer. Two candidate HPV vaccines, both …

Human papillomavirus, cervical cancer, and the vaccines

JM Tovar, OV Bazaldua, L Vargas… - Postgraduate …, 2008 - Taylor & Francis
How are human papillomavirus (HPV), cervical cancer, and the recently developed HPV
vaccines associated with each other? Human papillomavirus is a highly prevalent infection …

Les vaccins contre les papillomavirus

P Coursaget, A Touzé - Virologie, 2006 - jle.com
In the last 15 years, fifteen of the human papillomaviruses (HPVs) that infect the genital tract
have been recognized as the etiological agents of cervical cancer. Cervical cancer is thus a …